Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Biologics
Top 10 biologics approved in 2023
Biologics
,
EMA
,
FDA
,
Monoclonal antibody
,
Vaccines
Development and regulation of veterinary monoclonals
Biologics
,
Drug development
,
Regulatory
,
Veterinary biologics
Impact of immunogenicity on efficacy and safety of biosimilars – importance of ADA and nAb testing during the clinical development
Biologics
,
Drug product
Mycoplasma contamination in biopharmaceutical manufacturing
Biologics
,
Cell culture
,
Contamination
,
Manufacturing
Impact of glycosylation on the effector functions of monoclonal antibodies: a case study of rituximab
Bioanalytics
,
Biologics
,
Drug substance
,
Manufacturing
Previous
1
…
3
4